Dr. Peter Tapley
Dr. Tapley’s expertise is based on 28 years of experience in the biotechnology and pharmaceutical industry. His previous appointments include scientist and management roles at Ligand Pharmaceuticals and GlaxoSmithKline in the US. Prior to that, he was a post-doctoral researcher at Bristol Myers Squibb and the Fred Hutchinson Cancer Research Centre. He also has 15 years of experience in the rodent toxicology CRO sector which includes ‘hands-on’ experience as a Study Director managing GLP studies and more recently as Test Facility Management at TetraQ. Dr. Tapley is motivated by his belief in drug discovery and development and brings that commitment to support the contract studies conducted at TetraQ.